| __timestamp | Novavax, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 79435000 | 382096000000 |
| Thursday, January 1, 2015 | 162644000 | 345927000000 |
| Friday, January 1, 2016 | 237939000 | 312303000000 |
| Sunday, January 1, 2017 | 168435000 | 325441000000 |
| Monday, January 1, 2018 | 173797000 | 368298000000 |
| Tuesday, January 1, 2019 | 113842000 | 492381000000 |
| Wednesday, January 1, 2020 | 747027000 | 455833000000 |
| Friday, January 1, 2021 | 2534508000 | 526087000000 |
| Saturday, January 1, 2022 | 1235278000 | 633325000000 |
| Sunday, January 1, 2023 | 737502000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Novavax, Inc. have demonstrated contrasting approaches to R&D investment. Takeda, a global leader, consistently allocated substantial resources, with R&D expenses peaking at approximately 730 billion yen in 2023, marking a 91% increase since 2014. In contrast, Novavax, a smaller yet dynamic player, saw its R&D spending skyrocket by over 3,000% from 2014 to 2021, driven by its pivotal role in vaccine development. However, 2023 saw a decline in Novavax's R&D investment, highlighting the volatility in the biotech sector. This comparison underscores the diverse strategies in pharmaceutical innovation, where established giants and agile newcomers navigate the complex landscape of drug discovery and development.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and CymaBay Therapeutics, Inc.
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Travere Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: BeiGene, Ltd. vs Novavax, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and Novavax, Inc.
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Novavax, Inc.
R&D Insights: How Dynavax Technologies Corporation and Novavax, Inc. Allocate Funds
R&D Insights: How Novavax, Inc. and MiMedx Group, Inc. Allocate Funds